Mimedx (MDXG) Return on Capital Employed (2011 - 2026)

Mimedx has disclosed Return on Capital Employed across 15 years of filings, most recently posting 14.08% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 14.08%, down 993.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 14.08% (down 993.0% YoY), and the FY2025 annual result was 26.73%, down 186.0% from the prior year.
• Return on Capital Employed came in at 14.08% for Q1 2026 at Mimedx, down from 23.97% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 34.03% in Q2 2024 to a low of 19.82% in Q3 2022.
• The 5-year median for Return on Capital Employed is 21.78% (2025), against an average of 13.24%.
• Across the five-year window, Return on Capital Employed surged 4350 bps in 2023 and plunged 1544 bps in 2025, its largest moves.
• Mimedx's Return on Capital Employed stood at 11.46% in 2022, then soared by 293 bps to 22.09% in 2023, then advanced by 28 bps to 28.26% in 2024, then declined by 15 bps to 23.97% in 2025, then plunged by 41 bps to 14.08% in 2026.
• The last three Return on Capital Employed figures came in at 14.08% (Q1 2026), 23.97% (Q4 2025), and 21.78% (Q3 2025), per Business Quant data.